Evidence map›Paper›PMID 16288313›Full record

ArticleMolecular psychiatry2006

Genome scan on Swedish Alzheimer's disease families.

A Sillén, C Forsell, L Lilius, K Axelman, B F Björk, P Onkamo, J Kere, B Winblad, C Graff

Abstract readComparative StudyControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 42 citations in OpenAlex.

  1. Genes · 2021
    Article
  2. Article
  3. Article
  4. Genetic of Alzheimer's Disease: A Narrative Review Article.Iranian journal of public health · 2015
    Review
  5. Article
  6. Article
  7. Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2008
    Article
  8. Review
  9. New Alzheimer's disease locus on chromosome 8.Journal of medical genetics · 2006
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

A SillénDepartment Neurotec, Karolinska Institutet Sumitomo Pharmaceuticals Alzheimer Center, Karolinska Institutet, Novum, Huddinge, Sweden.
C Forsell
L Lilius
K Axelman
B F Björk
P Onkamo
J Kere
B Winblad
C Graff
Karolinska Institutet · SEKarolinska University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is an age-related disease, which affects approximately 40% of the population at an age above 90 years. The heritability is estimated to be greater than 60% and there are rare autosomal dominant forms indicating a significant genetic influence on the disease process. Despite the successes in the early 1990s when four genes were identified, which directly cause the disease (APP, PSEN1 and PSEN2) or greatly increase the risk of disease development (APOE), it has proved exceedingly difficult to identify additional genes involved in the pathogenesis. However, several linkage and association studies have repeatedly supported the presence of susceptibility genes on chromosomes (chrms) 9, 10 and 12. The study populations have, however, mostly been of great genetic heterogeneity, and this may have contributed to the meagre successes in identifying the disease associated genetic variants. In this study, we have performed a genome wide linkage study on 71 AD families from the relatively genetically homogeneous Swedish population where it is also possible to study the genetic ancestry in public databases. We have performed nonparametric linkage analyses in the total family material as well as stratified the families with respect to the presence or absence of APOE varepsilon4. Our results suggest that the families included in this study are tightly linked to the APOE region, but do not show evidence of linkage to the previously reported linkages on chrms 9, 10 and 12. Instead, we observed the next highest LOD score on chromosome 5q35 in the total material. Further, the data suggest that the major fraction of families linked to this region is APOE varepsilon4 positive.

Indexed as

Genome, HumanAgedAlzheimer DiseaseApolipoprotein E4Apolipoproteins ECase-Control StudiesChromosome MappingChromosomes, Human, Pair 5FemaleGenetic Predisposition to DiseaseHumansLod ScoreMaleMicrosatellite RepeatsMiddle AgedPedigreeApolipoprotein E4Apolipoproteins E

Identifiers

PMID16288313
OpenAlexW2009056478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.